PULM

Pulmatrix, Inc. PULM

PULM
Pulmatrix, Inc. DARE
Daré Bioscience, Inc. LPTX
Leap Therapeutics, Inc. HOTH
Hoth Therapeutics, Inc. ASBP
Aspire Biopharma Holdings, Inc. PALI
Palisade Bio, Inc. ADTX
Aditxt, Inc. CRIS
Curis, Inc. FBLG
FibroBiologics, Inc. Common Stock LGVN
Longeveron Inc.

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode PULM DARE LPTX HOTH ASBP PALI ADTX CRIS FBLG LGVN
6M -66.89 % -17.80 % 314.45 % -12.61 % -59.52 % 203.16 % -99.38 % -51.61 % -67.25 % -58.08 %
YTD -70.39 % -32.61 % -63.66 % 35.05 % -99.16 % 18.28 % -99.98 % -75.24 % -88.15 % -70.26 %
1Y -63.82 % -34.24 % -60.74 % 36.84 % -99.16 % 24.29 % -99.98 % -66.56 % -89.79 % -71.07 %
3Y -31.57 % -78.47 % -72.98 % -66.12 % -99.16 % -91.85 % -100.00 % -88.83 % -99.19 % -98.20 %
5Y -90.48 % -86.20 % -94.71 % -97.48 % -99.16 % -99.94 % -100.00 % -99.33 % -99.19 % -99.28 %
10Y -99.71 % -99.50 % -98.51 % -99.51 % -99.16 % -100.00 % -100.00 % -99.63 % -99.19 % -99.28 %
From the beginning -99.94 % -99.74 % -98.51 % -99.51 % -99.16 % -100.00 % -100.00 % -99.96 % -99.19 % -99.28 %

Dividend